Trademark: 86646133
Word
MMJ
Status
Dead
Status Code
602
Status Date
Tuesday, October 9, 2018
Serial Number
86646133
Mark Type
4000
Filing Date
Friday, May 29, 2015
Abandoned Date
Friday, September 14, 2018

Trademark Owner History
MMJ PHYTOTECH LIMITED -
UNITED GREENERIES HOLDINGS LTD. - 1st New Owner Before Publication
MMJ Bioscience Inc. - Original Applicant

Classifications
5 cannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; Pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; nutritional and dietary supplements; nutritional and dietary supplements for general health and wellbeing; magnetically encoded cards, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; magnetically encoded identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; consumer products, namely, edible oils; consumer products, namely, non-alcoholic beverages, namely, soft drinks, fruit drinks, vegetable drinks, and juices; consumer products, namely, smokeless vaporizer pipes and pens; online retail store wholesale services featuring CBD based pharmaceutical and body care products derived from industrial hemp; mail order buying clubs in the field of pharmaceutical products; membership services, namely, the operation and maintenance of an association promoting the interests of retail and wholesale stores in the field of medical marihuana; retail and wholesale store services featuring CBD based pharmaceutical products derived from industrial hemp; retail and wholesale store services featuring pharmaceuticals containing CBDs; promoting the goods and services of others by issuance of rewards cards related to the purchase of CBD based products; retail and wholesale store reward programs to promote the sale of pharmaceuticals containing CBDs; providing a customer loyalty program which promotes the goods and services of others by offering rewards, bonus points or discount offers; providing a website featuring information regarding political and business information regarding the cannabis industry; providing a website and online computer database featuring information regarding health; assembly of pharmaceuticals for others; customized production of pharmaceuticals, pharmaceutical products, nutraceuticals and CBD based products derived from industrial hemp; extraction of CBD derived from industrial hemp; scientific research services in the area of CBD based products derived from industrial hemp; product development services for products containing CBD based products derived from industrial hemp; research and development of products containing CBDs for others for clinical studies; operation of a web site that provides online social networking; Providing a website featuring legal information regarding cannabis and CBDs based products derived from industrial hemp

Trademark Events
Oct 9, 2018
Abandonment Notice Mailed - Failure To Respond
Oct 9, 2018
Abandonment - Failure To Respond Or Late Response
Mar 13, 2018
Notification Of Non-Final Action E-Mailed
Mar 13, 2018
Non-Final Action E-Mailed
Mar 13, 2018
Non-Final Action Written
Feb 21, 2018
Automatic Update Of Assignment Of Ownership
Feb 20, 2018
Lie Checked Susp - To Atty For Action
Aug 9, 2017
Notification Of Letter Of Suspension E-Mailed
Aug 9, 2017
Letter Of Suspension E-Mailed
Aug 9, 2017
Suspension Letter Written
Jul 5, 2017
Teas/Email Correspondence Entered
Jul 5, 2017
Correspondence Received In Law Office
Jun 27, 2017
Teas Response To Suspension Inquiry Received
Feb 8, 2017
Automatic Update Of Assignment Of Ownership
Jan 12, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 12, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 7, 2017
Notification Of Inquiry As To Suspension E-Mailed
Jan 7, 2017
Inquiry To Suspension E-Mailed
Jan 7, 2017
Suspension Inquiry Written
Jan 6, 2017
Lie Checked Susp - To Atty For Action
Jun 17, 2016
Notification Of Letter Of Suspension E-Mailed
Jun 17, 2016
Letter Of Suspension E-Mailed
Jun 17, 2016
Suspension Letter Written
May 17, 2016
Teas/Email Correspondence Entered
May 17, 2016
Correspondence Received In Law Office
May 12, 2016
Assigned To Lie
Apr 29, 2016
Teas Change Of Correspondence Received
Apr 29, 2016
Teas Response To Office Action Received
Nov 2, 2015
Notification Of Non-Final Action E-Mailed
Nov 2, 2015
Non-Final Action E-Mailed
Nov 2, 2015
Non-Final Action Written
Oct 20, 2015
Assigned To Examiner
Jun 16, 2015
Assigned To Examiner
Jun 15, 2015
Assigned To Examiner
Jun 5, 2015
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24